Week of —
This week's signal
New deals
—
New mentions
—
BFY CANARY TRACKER
Big Food Portfolio Rotation
Week of —
Last refreshed
Seventeen conglomerates. Hundreds of brands. The PMs at the top have always been buying and selling — that's the job. The news isn't that they're rotating. The news is which way, and how fast: legacy out, better-for-you in, at a clip that's stopped looking like housekeeping and started looking like a thesis trade.
Demand pulled first. GLP-1 cohorts are restructuring three categories at once. MAHA / SNAP just took $830M of legacy velocity off shelf in 23 states. Gen-Z pays a premium for the cleaner label. The PMs are answering in size: $137B sold, $35B bought into BFY, 99 transactions since 2019 — capped (so far) by McCormick × Unilever Foods at $45B on Jun 17, the largest single move in the log. This tracker is the tape: every buy, every sell, every PM, in order.
The story public trade commentary is telling is the wrong number by roughly 40%.
Barilla — 150 years old, fourth-generation family — has agreed to acquire Goodles. Terms were not disclosed. Goodles will operate as a stand-alone brand within Barilla Group. Trade commentary is floating "low-to-mid nine figures." Our estimate lands at $275–350M, centered on $300M — the low end of that range. The estimate rests on one adjustment most public analysis is skipping: the headline revenue figures are retail sales at the register, not company net revenue. Applying a sector multiple to the wrong numerator inflates implied price by roughly 40%.
Founded October 2020 as Gooder Foods in Santa Cruz. Launched November 2021. Founders: Jen Zeszut, Paul Earle (ex-Kraft), Molly Michet (CPO), Deb Luster (fmr. Annie's president); Gal Gadot as founding partner. 2024: ~$70M US retail sales; first profitable year. Current: $100M+ retail run rate (estimated). Capital raised: ~$19.4M disclosed. Roughly 6.7x of retail revenue per dollar of disclosed capital in is the headline efficiency number, and it is why this clears as a good outcome regardless of where the price actually landed.
Sector benchmark entering 2026 was approximately 3.1x EV/sales and 14.7x EV/EBITDA, with EBITDA multiples compressing toward 10–11x through 2025. Bachan's / Marzetti (Feb 2026, $400M at ~4.6x on ~$87M TTM) is the governing comp — single-category, fast-growing, sold to a mid-size strategic buying a shelf position it could not build organically. It sets the practical ceiling at ~4.6x. Hain N.A. snacks at 0.34x sets the floor and the warning: scaled revenue without profit converts to under one turn.
This is the analytical core. The $70M and $100M+ figures are retail sales at the register. Company net shipped revenue in packaged food typically runs 60–70% of retail dollars after retailer margin, trade spend, and promotional allowances. That puts Goodles at an estimated $65–80M of net revenue, not $100M+. The naive retail read at 3.1–4.6x produces $310–460M. The correct net-revenue read at 3.5–4.5x produces $230–360M. Sector average on net revenue: $200–250M. The EBITDA cross-check reinforces the mid: first profit in 2024 on a co-packed boxed pasta business implies a mid-single-digit EBITDA margin — call it $5–10M. Even at a generous 16x strategic multiple, that produces $80–160M. The distance between that and the revenue math is the entire negotiation, and it argues firmly against the top of the range.
Barilla is a fourth-generation family-owned company approaching its 150th year. It is not PepsiCo in a competitive process. Family strategics with long horizons underwrite to durability, not narrative, and they do not need to win an auction to justify a quarter. Landing on $300M: roughly 4x net revenue and ~3x retail run rate — a premium to the sector on the strength of category velocity and growth, but short of Bachan's 4.6x because growth is decelerating off a triple-digit base and the margin structure is thinner.
Barilla precedent: Late 2022, Barilla acquired Back to Nature from B&G Foods and, per trade commentary, "quickly turned the brand around" (CPGWire). That's the direct playbook — buy an underinvested better-for-you asset from a distressed portfolio holder, run it as a stand-alone brand, and rebuild velocity through the Barilla shelf and DSD footprint. Goodles is the same mechanic run on a growth asset instead of a turnaround.
Cap table (per CPGWire and Iris Finance): L Catterton (Series A lead, Sep 2023, $88M post), Springdale Ventures, Willow Growth Partners (all three led by Deborah Benton and Amanda Schutzbank — Willow does not typically invest pre-launch and made an exception), Third Craft, plus David Grutman and Electric Feel Ventures on the cultural-distribution layer. That layer is the underrated Goodles story: the celebrity founding-partner slot (Gal Gadot) is the visible part; the operator-plus-culture syndicate below the fold is what actually built the outcome.
At $300M and assuming no structure: L Catterton ($13M at $88M post → ~15% pre-dilution) → ~$45M proceeds → ~3.5x. Seed syndicate (pre-launch, materially lower mark) → ~10x. The pattern is familiar and worth naming: in capital-efficient consumer, the growth round buys a good multiple; the formation round buys the outcome.
Formation-stage entry is where the return sits in BFY food. A direct validation of NXP's stated posture — formation through Series A, not growth. Profitability is the exit trigger, not scale — Goodles turned profitable in 2024 at $70M retail and was acquired without a bridge, a Series B, or down-round pressure. For Cultivate Next and the Food is Foundation portfolio, the path to a strategic exit runs through EBITDA, not through the next raise. The window is open now: two-thirds of 2026 branded food M&A carried BFY or high-protein positioning. Categories raising venture capital today become targets in 18–36 months. Retail-vs-net discipline applies to our own marks — any portfolio company reporting retail sales figures should be carried at net revenue for valuation. The 30–40% gap is the difference between a defensible mark and an embarrassing one.
Upward, toward $400M+: genuine competitive tension (Kraft defending the mac-and-cheese shelf, General Mills protecting Annie's, or a PE platform); gross margin materially above the 25–45% category band; diversified velocity rather than concentration in two or three accounts. Downward, toward $200M: growth decelerating below ~30% on a normalized, trade-spend-adjusted basis; single co-packer dependency; retail concentration where one account holds the P&L.
Verdict: Formation-stage entry captures the outcome; growth-round entry captures the multiple. Treat the $275–350M range as directional for internal use, not a verified transaction value.
Full memo: NXP Investment Team, Sep 2, 2026.
The smartest thing RPV has done recently isn't the checks. It's the pivot.
Rich Products Ventures launched in 2017 as a food-tech CVC — cell-cultured seafood (BlueNalu 2020), precision-fermentation ingredients (MycoTechnology 2020, Phytolon 2024), sustainable-supply-chain software. Standard early-CVC playbook: chase the moonshots, ride the trend, hope one exits big.
Then the tape shifted, and RPV shifted with it. Over the last ten months — Jul 2025 through May 2026 — the fund printed five investments and the entire cohort is BFY-CPG:
Look at the archetype fit: Doughlicious (permissible-indulgence reformulator in frozen novelty), Ripple (pea-protein plant-milk reformulator), Evergreen (Eggo-attack frozen waffles), Jesse & Ben's (seed-oil-free frozen fries, MAHA-native), Phytolon (natural food-color platform — the ingredient shovel for MAHA-driven dye removal, which J.M. Smucker just publicly committed to). Four brand-level reformulator bets plus one ingredient-platform bet upstream of the exact reformulation the incumbents are being forced into. That is not a random portfolio. That is an operator building a thesis book.
Two things happening at once. First, most peer CVCs — General Mills 301 INC, Kellogg Ventures, Campbell's Acre Venture Partners — have slowed materially through 2024-2025 as parents restructured or ran cost programs. RPV kept deploying. Disciplined CVC capital is a scarce input when the founder needs a strategic that will actually pick up the phone. Second, RPV's strategic value is real, not theoretical. Rich Products runs three US frozen plants (Alabama, Kentucky, Colorado), owns Carvel + Jon Donaire + SeaPak + Farm Rich, and is a top-5 US frozen manufacturer by volume. For Doughlicious, Evergreen, and Ripple, that operational partnership is worth more than the check.
Bernstein has been direct on the podcast circuit: Thistle and Tovala are explicit GLP-1 bets — high-protein, high-fiber, nutrient-dense, portion-controlled. Ripple's pea-protein platform fits the same brief. That's three of eleven active portfolio companies pointed directly at the GLP-1 tailwind. Compare that to strategic peers still building thesis papers and it's the difference between framework and deployment.
RPV structures ~60% financial / 40% strategic — which means they will not overpay for pure alignment, and they will co-invest under a lead rather than set the round themselves ("we are traditionally a follower as an investor," per Bernstein). That has two implications for founders: the diligence bar is real (not an easier check because they're strategic), and RPV is additive capital, not a substitute for institutional VC leadership. The Doughlicious and Ripple leads are the exceptions, not the norm.
DPI. The fund is nine years old with one clear realized exit (Good Eggs, Aug 2024, undisclosed valuation), plus a few writedowns (Grabango out of business, Kitchen United out of business). Believer Meats' $347M Series B in 2021 was the marquee mark-up but cultivated-meat is currently a challenged asset class. If you're LP-shaped, the vintage still needs to prove out. If you're founder-shaped, it doesn't matter — the check clears and the manufacturing partnership is real.
RPV is one of two CVCs on the roster we'd point a founder at right now (the other is PowerPlant Partners for pure BFY brand). Reformulator archetype, active pace, real strategic value, disciplined pricing, on-thesis for both GLP-1 and MAHA. Watch the next print — if it's another frozen or beverage reformulator, RPV is running a book, not a hobby.
Verdict: The most disciplined food-focused CVC on the roster. Not the biggest check, not the flashiest brand. Just the most consistently correct thesis, quietly deployed while everyone else stopped.
Full RPV roster entry — open CAPITAL → Roster → filter “Corporate Venture”.